Skip to main content
Premium Trial:

Request an Annual Quote

For Those With a BlackBerry

BlackBerry and NantHealth have launched a secure cancer genome browser to enable clinicians to examine patients' genetic data from their BlackBerry smartphones, Reuters reports. BlackBerry bought a minority stake earlier this year in NantHealth, a cloud-based information technology provider, it adds.

According to BlackBerry, the browser will allow oncologists to view the mutations in a patient's cancer as they are uncovered and highlight treatment options, all within a secure, HIPAA-compliant framework.

"Our partnership with BlackBerry has really been able to create a scalable super-computer in the palm of the hands of the doctor," Patrick Soon-Shiong, chief executive of NantHealth, tells Reuters.

The companies add that they'll be demonstrating the browser at the January Consumer Electronics Show, and that they will be preloading it on some BlackBerry Passport devices. Reuters adds that the browser will also be available on some rival platforms, but secured by the BlackBerry network.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.